Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ JCVI

JCVI statement on a childhood varicella (chickenpox) vaccination programme

2023 ∙ JCVI

JCVI statement on the COVID-19 vaccination programme for autumn 2023 - updated on October 2023

2023 ∙ NIAC

NIAC RECOMMENDATIONS FOR PASSIVE IMMUNISATION AND VACCINATION AGAINST RESPIRATORY SYNCYTIAL VIRUS IN INFANTS, CHILDREN AND OLDER ADULTS

2023 ∙ ATAGI

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023 ∙ Conseil Supérieur de la Santé (CSS)

Vaccination of persons at risk of meningococcal infection in Belgium

2023 ∙ Haute Autorité de Santé

Vaccination strategy against pneumococcal infections - Place of pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) in adults

2023 ∙ Haute Autorité de Santé

Update of vaccination recommendations and obligations for students and professionals in the health and medico-social sectors and in close contact with young children 2/2

2023 ∙ Haute Autorité de Santé

Update of vaccination recommendations and obligations for students and professionals in the health and medico-social sectors and in close contact with young children 1/2